IMS Health seeks valuation of up to $6.97 bln in IPO - Reuters
IMS Health Holdings Inc said it expected to price its IPO at US$18-US$21 per share, valuing the healthcare information company at up to US$6.97 billion, Reuters reported. The company said the sale of 65 million shares was expected to raise about US$1.36 billion, based on the top end of the price range. The Danbury, Connecticut-based IMS was taken private in 2010 by TPG Capital LP, Canada Pension Plan Investment Board and Leonard Green & Partners LP for US$5.2 billion, including debt.
24 March 2014•1 min read
